Bergamottin (BG), a component of grapefruit juice, is a mechanism-based inactivator of cytochromes P450 (P450) 2B6 and 3A5 in the reconstituted system. The inactivation of both P450s was NADPH-dependent and irreversible. The kinetic constants for the inactivation of the 7-ethoxy-4-(trifluoromethyl)coumarin O-deethylation activity of P450 2B6 were: K(I), 5 microM; k(inact) 0.09 min(-1); and t1/2, 8 min. The kinetic constants obtained for the inactivation of the testosterone 6beta-hydroxylation activity of P450 3A5 were: K(I), 20 microM; k(inact) 0.045 min(-1); and t1/2, 15 min. Incubations of P450s 2B6 and 3A5 with 20 microM BG at 37 degrees C for 20 min resulted in an approximately 60% loss in the catalytic activity that was accompanied by a significant loss in intact heme and a similar decrease in the reduced CO difference spectrum. The extrapolated partition ratios for BG with P450s 2B6 and 3A5 were approximately 2 and approximately 20, respectively. Liquid chromatography-mass spectroscopy analysis of the BG-inactivated samples showed that the mass of the inactivated apoprotein had increased by approximately 388 Da for both P450 2B6 and P450 3A5. SDS-polyacrylamide gel electrophoresis analysis demonstrated that [14C]BG was irreversibly bound to the apoprotein in the BG-inactivated samples. The stoichiometry of binding was approximately 0.5 mol BG metabolite/mol of each P450 inactivated. High-pressure liquid chromatography analysis of the metabolites of BG showed that P450 2B6 generated two major metabolites, whereas P450 3A5 generated three additional metabolites. Two of metabolites were identified as 6',7'-dihydroxybergamottin and bergaptol.

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.104.079608DOI Listing

Publication Analysis

Top Keywords

2b6 3a5
16
p450 2b6
16
p450s 2b6
12
p450 3a5
12
p450
11
grapefruit juice
8
p450 p450
8
kinetic constants
8
constants inactivation
8
activity p450
8

Similar Publications

Age-Dependent Changes in Cytochrome P450 Abundance and Composition in Human Liver.

Drug Metab Dispos

November 2024

Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington

Article Synopsis
  • The Cytochrome P450 (CYP) superfamily is crucial for metabolizing over 65% of therapeutic drugs, making understanding their development in children important for drug dosing.
  • A study used hepatocytes from pediatric and adult donors to analyze age-dependent changes in CYP enzyme abundances, finding significant variations across different age groups.
  • The findings can enhance physiologically based pharmacokinetic (PBPK) modeling for more accurate and safer dosage predictions for pediatric patients based on adult pharmacokinetic data.
View Article and Find Full Text PDF

The effectiveness of antidepressant treatment for mood disorders is often limited by either a poor response or the emergence of adverse effects. These complications often necessitate multiple drug trials. This clinical challenge intensifies during pregnancy, when medications must be selected to improve the likelihood of response and optimize reproductive outcomes.

View Article and Find Full Text PDF

Data are presented on the formation of potentially toxic metabolites of drugs that are substrates of human drug metabolizing enzymes. The tabular data lists the formation of potentially toxic/reactive products. The data were obtained from in vitro experiments and showed that the oxidative reactions predominate (with 96% of the total potential toxication reactions).

View Article and Find Full Text PDF

Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes.

Pharmgenomics Pers Med

October 2023

Laboratory of Biotechnology, Environment, Agrifood, and Health, Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, Fez, Morocco.

Introduction: Clopidogrel is an antiplatelet prodrug primarily prescribed to prevent or treat acute coronary syndrome (ACS) or acute ischemic stroke (IS), polymorphisms of genes encoding cytochrome P-450 (CYP) and P-glycoprotein transporter, could affect the efficiency of clopidogrel absorption and biotransformation, especially during the first critical hours following its administration.

Methods: The present study was designed to investigate the potential association of clopidogrel responsiveness and 14 polymorphisms in the genes encoding the CYPs (CYP2C9, 2C19, 3A4, 3A5, 1A2, and 2B6), the ATP binding cassette subfamily B member 1 (ABCB1). Platelet aggregation activity was measured after 8h of 300mg clopidogrel administration for fifty-five ACS patients.

View Article and Find Full Text PDF

The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib.

Toxicol Sci

December 2023

Division of Biochemical Toxicology, National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, Arkansas 72079, USA.

Lapatinib, an oral tyrosine kinase inhibitor used as a first-line treatment for HER2-positive breast cancer, has been reported to be associated with hepatotoxicity; however, the underlying mechanisms remain unclear. In this study, we report that lapatinib causes cytotoxicity in multiple types of hepatic cells, including primary human hepatocytes, HepaRG cells, and HepG2 cells. A 24-h treatment with lapatinib induced cell cycle disturbances, apoptosis, and DNA damage, and decreased the protein levels of topoisomerase in HepG2 cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!